Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report) shares were down 3.6% on Thursday . The company traded as low as $67.50 and last traded at $67.50. Approximately 850 shares traded hands during mid-day trading, an increase of 145% from the average daily volume of 347 shares. The stock had previously closed at $70.00.
Bioqual Stock Performance
The firm has a fifty day simple moving average of $70.85 and a 200-day simple moving average of $73.24. The firm has a market cap of $60.75 million, a price-to-earnings ratio of 63.08 and a beta of -0.31.
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Stories
- Five stocks we like better than Bioqual
- What is the Australian Securities Exchange (ASX)
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to buy stock: A step-by-step guide for beginners
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- What Investors Need to Know About Upcoming IPOs
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
